MedTorque, Inc. – Trademark Portfolio

Entity Type: 03

MedTorque, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TRI-GEAR and MEDTORQUE. The owner is based in Kenosha, WI.

5601 95th Avenue

Kenosha, WI 53144

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MedTorque, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (6 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

40
Treatment & Processing (4 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does MedTorque, Inc. have?

MedTorque, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 cancelled.

What trademark classes does MedTorque, Inc. file in?

MedTorque, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are MedTorque, Inc.'s most well-known trademarks?

MedTorque, Inc.'s registered trademark portfolio includes well-known marks such as TRI-GEAR and MEDTORQUE. These are among 2 currently registered trademarks in the portfolio.

What is MedTorque, Inc.'s trademark registration success rate?

MedTorque, Inc. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.